FTSE 100 today: closes higher as UK inflation surprises; GBP lower, Ithaca report
HAUPPAUGE, N.Y. - United-Guardian, Inc. (NASDAQ:UG), a $40 million market cap manufacturer of cosmetic ingredients and various healthcare products, today announced the appointment of its President, Donna Vigilante, to its Board of Directors. The company, which maintains a strong gross profit margin of ~54% and generates annual revenue of $11.4 million, has received a "Good" financial health rating according to InvestingPro analysis. Ms. Vigilante, who has served the company for over two decades, brings a wealth of experience from her prior roles, including Vice President and Manager of the company’s Research & Development (R&D) and microbiology departments.
During her tenure, she played a critical role in the development of new products, particularly in the expansion of the company’s natural cosmetic ingredients line. The appointment is seen as a strategic move for United-Guardian as it seeks to enhance its global marketing strategies and boost sales across its medical and pharmaceutical product lines.
"I am extremely pleased and honored to be appointed to the company’s Board of Directors," said Ms. Vigilante. "I am very excited about the new initiatives we are implementing, including some significant changes we are making in the global marketing and distribution of our cosmetic ingredients and renewed emphasis on increasing the sales of our medical and pharmaceutical products."
Ms. Vigilante’s academic background includes a Bachelor of Science degree in biochemistry with a minor in business from Stony Brook University, equipping her with a strong foundation for her roles within the company.
This move comes as United-Guardian aims to navigate the competitive landscape of the healthcare and cosmetics industries. The company’s management team has expressed confidence in Ms. Vigilante’s abilities to contribute to the board’s oversight and strategic guidance.
The information provided in this announcement is based on a press release statement from United-Guardian, Inc. It should be noted that the press release contains forward-looking statements that involve risks and uncertainties, which may cause actual results to differ materially from those projected. According to InvestingPro analysis, the stock appears slightly undervalued based on its Fair Value assessment, with additional insights and detailed financial metrics available to subscribers. The company’s next earnings report is expected on August 8, 2025, which could provide further clarity on its strategic initiatives. These statements are made under the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. For more details on the potential risks and uncertainties that could impact the company’s business, interested parties are advised to consult United-Guardian’s filings with the Securities and Exchange Commission.
In other recent news, United-Guardian, Inc. held its annual stockholders meeting on May 15, 2025, resulting in the election of six directors to its board. The elected directors, including Ken Globus, Lawrence F. Maietta, Arthur M. Dresner, Andrew A. Boccone, S. Ari Papoulias, and Catherine Kolinski, will serve until the next annual meeting. Shareholders also approved the frequency of future votes on executive compensation to occur annually, with a notable majority voting in favor. Additionally, the appointment of Grassi & Co., CPAs P.C. as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified. These developments reflect strong shareholder support for the company’s current board and executive policies. The ratification of the accounting firm indicates confidence in United-Guardian’s financial reporting processes. United-Guardian continues to trade under the NASDAQ Global Market.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.